Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prenatal testing for hemolytic disease of the newborn and fetal neonatal alloimmune thrombocytopenia - current status.

Expert review of hematology - 1 Dec 2014

Avent Neil D

Abstract excerpt

Incompatibility of red cell and platelet antigens can lead to maternal alloimmunization causing hemolytic disease of the fetus & newborn and fetal neonatal alloimmune thrombocytopenia respectively. As the molecular background of these polymorphisms emerged, prenatal testing using initially fetal DNA obtained from invasively obtained amniotic fluid or chorionic villus was implemented. This evolved into testing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Human Platelet
Share to Blood Group Antigens
Share to Erythroblastosis, Fetal

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunotherapy

Share to Infant, Newborn

Share to Integrin beta3

Share to Pregnancy

Share to Prenatal Diagnosis

Source

Identifiers

PMID: 25374152
DOI: 10.1586/17474086.2014.970160

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prenatal testing for hemolytic disease of the newborn and fetal neonatal alloimmune thrombocytopenia - current status.PMID 25374152Read ↗

Noninvasive Prenatal Testing in Immunohematology—Clinical, Technical and Ethical ConsiderationsSemantic proximity Read ↗

Non-Invasive Prenatal Fetal Blood Group Genotype and Its Application in the Management of Hemolytic Disease of Fetus and Newborn: Systematic Review and Meta-Analysis.Semantic proximity Read ↗

How I use noninvasive prenatal testing for red blood cell and platelet antigensSemantic proximity Read ↗

Recent advances in non-invasive fetal HPA-1a typingSemantic proximity Read ↗

Noninvasive fetal genotyping of human platelet antigen-1a using targeted massively parallel sequencing.Semantic proximity Read ↗

Management of red cell alloimmunisation in pregnancy: the non-invasive monitoring of the disease.Semantic proximity Read ↗

Determination of human platelet antigen typing by molecular methods: Importance in diagnosis and early treatment of neonatal alloimmune thrombocytopenia.Semantic proximity Read ↗

Noninvasive Fetal HPA Genotyping for FNAIT: Diagnostic Accuracy and Technical Performance of Molecular Methods.Semantic proximity Read ↗

Feasibility for non-invasive prenatal fetal blood group and platelet genotyping by massively parallel sequencing: A single test system for multiple atypical red cell, platelet and quality control markers.Semantic proximity Read ↗

Guideline for blood grouping and red cell antibody testing in pregnancySemantic proximity Read ↗

Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects.Semantic proximity Read ↗

Foetal and neonatal alloimmune thrombocytopenia - The role of the HLA-DRB3*01:01 allele for HPA-1a-immunisation and foetal/neonatal outcome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.